Latest Commercial Sales News

Green360 Technologies has secured its first binding commercial supply agreement with Holcim Australia for up to 4,800 tonnes of its proprietary MKX-CC low-carbon cement replacement, marking a significant step from development to commercial sales amid tightening supplementary cementitious material supplies.

Li-S Energy marked key commercial and regulatory milestones in Q2 2026, including ISO 9001:2015 certification for its lithium foil line, first commercial foil sale, and US air transport approvals for lithium-sulfur cells. The company also completed a major Battery Testing Centre expansion and began deep-ocean cell testing with MSubs.

Syrah Resources moderated graphite output amid subdued ex-China demand, raised US$72 million to support ramp-up, and advanced Vidalia anode material towards commercial sales in H2 2026.

Green360 Technologies has locked in its inaugural commercial supply contract with Holcim Australia for up to 4,800 tonnes of its MKX-CC low-carbon cement replacement, marking its shift from development to commercial sales amid tightening supplementary cementitious material supplies.

PolyNovo has delivered solid FY26 revenue growth of 16.1%, driven by commercial sales expansion and improved manufacturing output, while progressing insurance recovery from its R&D centre fire.

Aguia Resources has completed a $3 million placement at a 10.5% discount, targeting expansion of its phosphate and gold operations in Brazil and Colombia.

MotorCycle Holdings has uncovered leave loading underpayments affecting current employees since 2020, with remediation costs estimated up to $1.3 million. The company is voluntarily engaging the Fair Work Ombudsman while conducting a complex review of historical payroll compliance.

Within six weeks of commissioning, Aguia Resources has secured over A$2.3 million in sales of its Pampafos organic phosphate fertiliser, marking a key transition to revenue-generating operations with deliveries scheduled through year-end.

Optiscan Imaging has begun commercial sales of its InSpecta™ microscopic imaging device in the US veterinary sector following FDA clearance, marking its first clinical device launch and a strategic expansion into a $15.87 billion market.

Neuren’s partner Acadia secures positive CHMP opinion for DAYBU® in Rett syndrome, paving the way for first EU treatment approval and triggering significant milestone payments for Neuren.

ECS Botanics has commenced commercial sales of Gelonoidz #20, its first Australian-grown Terphogz cultivar, marking a key step in expanding its premium medicinal cannabis portfolio with plans for more cultivars in FY27.

Aguia Resources has rapidly converted its Pampafós phosphate fertiliser project into commercial sales, securing AUD 600,000 in revenue within 14 days, anchored by a 2,000-tonne contract with a leading Brazilian agricultural cooperative.